Vladimir Dašić

Chambers and Partners’ 2015 European edition ranks BDK in all practice areas in Serbia and in Montenegro. The firm received Band 1 rankings in Banking & Finance; Corporate/Commercial and Dispute...
Read More
BDK advised Mylan in relation to the acquisition of Abbott’s established products business (EPD Business) in Bosnia and Herzegovina, as part of a USD 5.3 billion acquisition of Abbott’s non-U.S....
Read More
The latest Chambers Global review again ranks BDK a Band 1 firm in both Serbia and Montenegro. Tijana Kojović, Vladimir Dašić, Dragoljub Cibulić and Luka Popović are ranked as individuals....
Read More
BDK advised a Swiss based company Newmet International AG on a successful takeover bid for the acquisition of majority shares in Nissal AD. Nissal AD is the Serbian company with...
Read More
BDK’s newly formed Life Sciences and Healthcare practice group synergizes our firm’s existing capacity in regulatory work, corporate, finance, competition, data protection, IP, product liability and litigation, upgrading it with...
Read More
BDK Advokati/Attorneys at Law advised the owners of Serbian food processor Foodland on the sale of the company to Croatia’s Atlantic Grupa, regional leader in the food and beverages sector. Foodland...
Read More
BDK’s Senior Partner Vladimir Dašić gave presentation on overcoming legal challenges that investors face in SEE. The event was held in Belgrade on 7 October 2014.
Read More
BDK Advokati/Attorneys at Law advised Resource Partners on its acquisition of major Serbian gym and fitness chain World Class. Resource Partners (www.resourcepartners.eu) is an private equity investor focusing exclusively on targets...
Read More
BDK’s Head of M&A Practice Vladimir Dašić has provided an insight in the current investment climate in Serbia for a special Serbian report published by “The Lawyer”.
Read More
BDK Advokati/Attorneys at Law has advised private equity fund Blue Sea Capital on its acquisition of Milos Klinika, a leading ophthalmology clinic based in Belgrade, Serbia. After creating the MediGroup...
Read More
1 7 8 9 10 11

ARCHIVE